Caldera announces: its native token ERA's core network has deeply integrated zero-knowledge proofs (ZK-SNARKs) and medical data on-chain protocols, becoming the first Layer2 infrastructure to achieve "genetic data available but invisible"! A certain cancer early screening project has reduced the risk of genetic testing data leakage from 0.3% to 0.0003% using this technology, bringing down testing costs by 70%, which directly triggered a 22% surge in the ERA/USDT price.
The technical barriers of this "medical data revolution" are Caldera's unique three-layer privacy architecture:
1. Data sharding on-chain: Genetic sequence data is split into 128 fragments, stored across 128 distributed nodes, which helped a genetic disease research project avoid a 300GB data leakage risk.
2. Dynamic permission control: Smart contracts automatically match doctor qualifications with patient authorizations, allowing a top-tier hospital to shorten data access approval time from 3 days to 10 minutes through this feature.
3. Zero-knowledge verification: Doctors can prove the correctness of diagnostic conclusions using ZK-SNARKs without accessing the original data, which has improved the efficiency of rare disease diagnosis by 5 times.
Even crazier, Caldera integrates the Chainlink CCIP protocol through a medical oracle network to achieve private transmission of cross-hospital testing data— a multinational pharmaceutical company used this technology to shorten the clinical trial period for new drugs from 18 months to 12 months, saving $200 million in research and development costs. Now holding ERA allows you to enjoy the Layer2 expansion dividend and earn an annualized return of 14%-27% through staking—this operation is 100 times more secure than traditional medical data cloud services!
